IRBESARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE

Compare IRBESARTAN (Irbesartan) and TELMISARTAN AND HYDROCHLOROTHIAZIDE (telmisartan and hydrochlorothiazide) — clinical data, side effects, and patient experiences.

IRBESARTAN

Irbesartan, Avapro, Avalide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Irbesartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. ( 1.1 ) Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes

an elevated serum creatinine

OralTablet

TELMISARTAN AND HYDROCHLOROTHIAZIDE

telmisartan and hydrochlorothiazide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

IRBESARTANTELMISARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

IRBESARTAN

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Falls

1-10%

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

IRBESARTAN

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume or salt depletion prior to administration
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe heart failure, or volume depletion) may be at particular risk of developing acute renal failure or death on irbesartan tablets

TELMISARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia, or acute renal failure on telmisartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for IRBESARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE.

IRBESARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Both IRBESARTAN and TELMISARTAN AND HYDROCHLOROTHIAZIDE belong to the ARB class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Shared Indications

Both medications are approved for to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Safety Considerations

IRBESARTAN carries 4 FDA warnings. TELMISARTAN AND HYDROCHLOROTHIAZIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

IRBESARTAN vs SACUBITRIL AND VALSARTAN→SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE→IRBESARTAN vs VALSARTAN→TELMISARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN→IRBESARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→IRBESARTAN vs TELMISARTAN→

Loading comparison data...

IRBESARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE

Compare IRBESARTAN (Irbesartan) and TELMISARTAN AND HYDROCHLOROTHIAZIDE (telmisartan and hydrochlorothiazide) — clinical data, side effects, and patient experiences.

IRBESARTAN

Irbesartan, Avapro, Avalide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Irbesartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. ( 1.1 ) Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes

an elevated serum creatinine

OralTablet

TELMISARTAN AND HYDROCHLOROTHIAZIDE

telmisartan and hydrochlorothiazide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

IRBESARTANTELMISARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

IRBESARTAN

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Falls

1-10%

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

IRBESARTAN

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume or salt depletion prior to administration
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe heart failure, or volume depletion) may be at particular risk of developing acute renal failure or death on irbesartan tablets

TELMISARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia, or acute renal failure on telmisartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for IRBESARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE.

IRBESARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Shared Indications

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.